key: cord-0808685-tq630a4f
authors: Cardona‐Hernandez, Roque; Cherubini, Valentino; Iafusco, Dario; Schiaffini, Riccardo; Luo, Xiaoping; Maahs, David M
title: Children and youth with diabetes are not at increased risk for hospitalization due to COVID‐19
date: 2020-11-26
journal: Pediatr Diabetes
DOI: 10.1111/pedi.13158
sha: 74234c4c12cdae81a60aa7c62c5436491255deed
doc_id: 808685
cord_uid: tq630a4f

The severe acute respiratory syndrome coronavirus 2 (SARS‐Cov‐2), responsible for the coronavirus disease COVID‐19, was first identified in Wuhan, China in December 2019. Diabetes, as well as other cardiovascular comorbidities, has been recognized as a major risk factor for outcomes and mortality in adults with COVID‐19, particularly in the elderly with type 2 diabetes. Based on these conclusions, COVID‐19 data on adults have been generalized to youth with diabetes. Nevertheless, experience from pediatric diabetes practices in China (Wuhan), Italy, Spain (Catalonia), and the United States (San Francisco Bay Area) consistently report only a single severe case of COVID‐19 in a 20‐year‐old female youth with type 1 diabetes (T1D) that was hospitalized for bilateral pneumonia and was subsequently discharged without complications. In Italy, information on COVID‐19 in all children with diabetes is collected on a weekly basis and those with positive swab test or infection‐related symptoms reported to a dedicated national registry. Of a total of 15 500 children tested, 11 subjects with T1D (age 8‐17y) tested positive for COVID‐19; 6/11 were asymptomatic and the rest presented with mild symptoms. In the rest of locations, youths with T1D diagnosed with COVID‐19 were based on clinical suspicion and a confirmatory PCR test (Wuhan:0; Catalonia‐HSJD:3; California‐Stanford:2). All of them were asymptomatic or had a mild course. We suggest that COVID‐19 data from adults should not be generalized to children, adolescents, and youth with diabetes as their outcomes and prognosis seem to be similar to their non‐diabetic‐peers and consistently milder than adults with diabetes.

adults have been generalized to youth with diabetes. Nevertheless, experience from pediatric diabetes practices in China (Wuhan), Italy, Spain (Catalonia), and the United States (San Francisco Bay Area) consistently report only a single severe case of COVID-19 in a 20-year-old female youth with type 1 diabetes (T1D) that was hospitalized for bilateral pneumonia and was subsequently discharged without complications. In Italy, information on COVID-19 in all children with diabetes is collected on a weekly basis and those with positive swab test or infection-related symptoms reported to a dedicated national registry. Of a total of 15 500 children tested, 11 subjects with T1D (age 8-17y) tested positive for COVID-19; 6/11 were asymptomatic and the rest presented with mild symptoms. In the rest of locations, youths with T1D diagnosed with COVID-19 were based on clinical suspicion and a confirmatory PCR test (Wuhan:0; Catalonia-HSJD:3; California-Stanford:2). All of them were asymptomatic or had a mild course. We suggest that COVID-19 data from adults should not be generalized to children, adolescents, and youth with diabetes as their outcomes and prognosis seem to be similar to their non-diabetic-peers and consistently milder than adults with diabetes. By July 2020, more than 12 million confirmed cases and almost 600 000 deaths had been reported by WHO 2 and the disease threatens healthcare systems worldwide. Since the beginning of the pandemic, diabetes, as well as other cardiovascular comorbidities such as obesity and hypertension, has been recognized as a major risk factor for outcomes and mortality of COVID-19. 3 (Table 2) . Only three cases required hospitalization. Two of these cases were asymptomatic and required hospitalization at onset for diabetes education, but not for COVID-19 complications.

The other case required hospitalization due to diabetic ketoacidosis (DKA) with a routine COVID-19 test performed at Intensive Care Unit admission. These findings are consistent with reports that children and adolescents, when infected, 10 suffer a milder, and frequently asymptomatic clinical course and are at lower risk of hospitalization. [11] [12] [13] A recent questionnaire-based study from the T1DX QI initiative that collected data on subjects with T1D from 49 endocrinology clinics at United States. reported that the most prevalent adverse outcome within COVID-19 positive patients was DKA. Two deaths were reported and both of these were in people >18 years of age. 14 It is important to convey that morbidity and mortality reports in adults with diabetes should not be generalized to children, adolescents, and young adults. This perspective was advanced in a recent commentary. 18 Our brief report, with an international perspective, adds to the current knowledge that children, adolescents, and youth with diabetes are not at increased risk for hospitalization due to COVID-19. A large multicenter European report on Covid-19 with 582 individuals with PCR-confirmed SARS-CoV-2 infection, reported no cases in children and adolescents with preexisting diabetes, 19 consistent with our report. We reiterate and update the following points from the International Society for Pediatric and Adolescent Diabetes Statement "Keep Calm and Mind your Diabetes Care and Public Health Advice" 20 :

1. We report a single case of a youth <25 years of age with diabetes hospitalized due to COVID-19 with a positive outcome. 

Rolling updates on coronavirus disease (COVID-19)

World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard. 2020

Effects of hypertension, diabetes and coronary heart disease on COVID-19 diseases severity: a systematic review and meta-analysis. Endocrinology. 2020 Available from

Diabetes increases the mortality of patients with COVID-19: a meta-analysis

glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States

Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome

COVID-19: vulnerable and high risk groups 2020

Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 -United States

Practical recommendations for the management of diabetes in patients with COVID-19

Detection of Covid-19 in Children in Early

SARS-CoV-2 infection in children

Spread of SARS-CoV-2 in the Icelandic population

Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults

Type 1 diabetes and COVID-19: preliminary findings from a multicenter surveillance study in the U

Unintended consequences of COVID-19: remember general pediatrics

the Diabetes Study Group of the Italian Society for Pediatric Endocrinology and Diabetes*. Has COVID-19 delayed the diagnosis and worsened the presentation of type 1 diabetes in children? Diabetes Care

Ketoacidosis in children and adolescents with newly diagnosed type 1 diabetes during the COVID-19 pandemic in Germany

COVID-19 and children with diabetes-updates, unknowns, and next steps: first, do no extrapolation

COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study

Summary of recommendations regarding COVID −19 in children with diabetes: Keep Calm and Mind your Diabetes Care and Public Health Advice

COVID-19, type 1 diabetes, and technology: why paediatric patients are leading the way

Children and youth with diabetes are not at increased risk for hospitalization due to COVID-19